Cargando…

A novel score predicts mortality after transjugular intrahepatic portosystemic shunt: MOTS ‐ Modified TIPS Score

BACKGROUND AND AIMS: The high risk for severe shunting‐related post‐interventional complications demands a stringent selection of candidates for transjugular intrahepatic portosystemic shunt (TIPS). We aimed to develop a simple and reliable tool to accurately predict early post‐TIPS mortality. METHO...

Descripción completa

Detalles Bibliográficos
Autores principales: Fürschuß, Luisa, Rainer, Florian, Effenberger, Maria, Niederreiter, Markus, Portugaller, Rupert H., Horvath, Angela, Fickert, Peter, Stadlbauer, Vanessa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9539997/
https://www.ncbi.nlm.nih.gov/pubmed/35261130
http://dx.doi.org/10.1111/liv.15236
Descripción
Sumario:BACKGROUND AND AIMS: The high risk for severe shunting‐related post‐interventional complications demands a stringent selection of candidates for transjugular intrahepatic portosystemic shunt (TIPS). We aimed to develop a simple and reliable tool to accurately predict early post‐TIPS mortality. METHODS: 144 cases of TIPS implantation were retrospectively analysed. Using univariate and multivariate Cox regression analysis of factors predicting mortality within 90 days after TIPS, a score integrating urea, international normalized ratio (INR) and bilirubin was developed. The Modified TIPS‐Score (MOTS) ranges from 0 to 3 points: INR >1.6, urea >71 mg/dl and bilirubin >2.2 mg/dl account for one point each. Additionally, MOTS was tested in an external validation cohort (n = 187) and its performance was compared to existing models. RESULTS: Modified TIPS‐Score achieved a significant prognostic discrimination reflected by 90‐day mortality of 8% in patients with MOTS 0–1 and 60% in patients with MOTS 2–3 (p < .001). Predictive performance (area under the curve) of MOTS was accurate (c = 0.845 [0.73–0.96], p < .001), also in patients with renal insufficiency (c = 0.830 [0.64–1.00], p = .02) and in patients with refractory ascites (c = 0.949 [0.88–1.00], p < .001), which are subgroups with particular room for improvement of post‐TIPS mortality prediction. The results were reproducible in the validation cohort. CONCLUSIONS: Modified TIPS‐Score is a novel, practicable tool to predict post‐TIPS mortality, that can significantly simplify clinical decision making. Its practical applicability should be further investigated.